Vered Stearns

Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vered Stearns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
exemestane Medicine & Life Sciences
Hot Flashes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
letrozole Medicine & Life Sciences
Cytochrome P-450 CYP2D6 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Burstein, H. J., Lacchetti, C., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. A., Giordano, S. H., Hudis, C. A., Solky, A. J., Stearns, V., Winer, E. P. & Griggs, J. J., Feb 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 5, p. 423-438 16 p.

Research output: Contribution to journalArticle

Practice Guidelines
Hormones
Breast Neoplasms
Aromatase Inhibitors
Therapeutics

Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

Dempsey, J. M., Kidwell, K. M., Gersch, C. L., Pesch, A. M., Desta, Z., Storniolo, A. M., Stearns, V., Skaar, T. C., Hayes, D. F., Henry, N. L., Rae, J. M. & Hertz, D. L., Jan 1 2019, In : Pharmacogenomics. 20, 8, p. 571-580 10 p.

Research output: Contribution to journalArticle

exemestane
letrozole
Aromatase Inhibitors
Estrogens
Breast Neoplasms

Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion

Kamdem, L. K., Xi, J., Clark, B. L., Gregory, B. J., Kidwell, K. M., Storniolo, A. M., Stearns, V., Hayes, D. F., Gersch, C. L., Rae, J. M., Henry, N. L. & Hertz, D. L., Jan 1 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

exemestane
letrozole
Gene Deletion
Women's Health
Aromatase Inhibitors

High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

Gorbounov, M., Carleton, N. M., Asch-Kendrick, R. J., Xian, L., Rooper, L., Chia, L., Cimino-Mathews, A., Cope, L., Meeker, A., Stearns, V., Veltri, R. W., Bae, Y. K. & Resar, L. M. S., Jan 1 2019, (Accepted/In press) In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

High Mobility Group Proteins
Estrogen Receptors
Breast Neoplasms
Gene Expression
Neoplasms

Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study

Wang, G., Chen, C., Pai, P., Korangath, P., Sun, S., Merino, V., Yuan, J., Li, S., Nie, G., Stearns, V. & Sukumar, S., Jul 20 2019, In : Carcinogenesis. 40, 7, p. 903-913 11 p.

Research output: Contribution to journalArticle

Carcinoma, Intraductal, Noninfiltrating
Estrogen Receptor alpha
Breast
Breast Neoplasms
Therapeutics